News & Events

Full Swing for MesenPlify sXF！

🙌 Absolutely thrilled for yet another exciting chance to explore deeper into the potential of MesenPlify! Huge thanks to Minh and Trinh, from NUS Yong Loo Lin School of Medicine, for their incredible support of ​InnoCellular ​!

Meeting Allegrow in Hong Kong for Immune Cell Expansion Platform!

🤗 After our time in Shanghai, we’re making a pit stop to catch up with our friends at Allegrow Biotech in Hong Kong for their incredible platform for expanding immune cells! 🔬 Get ready to see how we join forces to boost innovation in cell therapy in Asia!

🎉 Successful Debut in CGTAsia Shanghai!

🎉 Here comes to the end of the successful first launch of InnoCellular with Applitech in CGTAsia Shanghai! What an amazing time of meeting you all in Shanghai! 🙋‍♀️

🥩 Cell Culture Media for Cultivated Meat!

InnoCellular is meeting our new friend Meatiply to explore the role of cell culture media in the field of cultivated meat! 🥩

📆 Conference Alert: CGTAsia2024 in Shanghai!

InnoCellular is participating, together with Applitech in CGTAsia 2024 in Shanghai, marking our debut in China! This collaboration signifies a significant milestone for us as we join forces to support cell therapy advancements in China. If you’re at CGTAsia, don’t miss out! Swing by our booth for some exciting updates and discussions!

[Press Release] International Partnerships of InnoCellular and Applitech to Accelerate Next-Generation Cell Therapy Advancements in Asia

International Partnerships of InnoCellular and Applitech to Accelerate Next-Generation Cell Therapy Advancements in Asia International partnership for Singapore-based InnoCellular collaborates with China-based Applitech to advance cell therapy in Asia. This partnership aims to provide comprehensive one-stop solutions to the cell therapy community in Asia. Singapore, March 6 2024 — Singapore-based InnoCellular Tech Pte Ltd (“InnoCellular”), […]

Jonathan is speaking at CGTAsia2024 in Shanghai!

Our co-founder Jonathan has been invited as a guest speaker at CGTAsia2024 in Shanghai! His exciting work in utilizing single-cell technology to derive NK cells with enhanced functionality and improved potency has earned him this opportunity to share his expertise on a global stage. Stay tuned for his insightful presentation at CGTAsia 2024!

The translation of technology to commercial product by our CSO at BMRC CRF Day!

Our co-founder Jonathan recently shared insights at the BMRC Central Research Fund (CRF) Day. He discussed translating benchwork technology into commercial success, bridging science and commerce. Congrats, Jonathan for the insightful sharing! Excited for the future availability of more technology as commercial products for the public!

[Press Release] InnoCellular Empowers Next-Generation Cell Therapy with Customizable Cell Culture Media Formulation Platform

InnoCellular Empowers Next-Generation Cell Therapy with the Customizable Cell Culture Media Formulation Platform InnoCellular introduces its customizable cell culture media formulation platform, in advancing the development of next-generation cell therapy. The platform encourages collaboration and innovation among research and clinical professionals, aiming to enhance the existing pipeline. Singapore, February 20 2024 — InnoCellular Tech Pte […]

InnoCellular is extending its footprint in Indonesia!

Delighted to announce our recent knowledge-sharing session together with The Cell Fate Engineering and Therapeutics Laboratory for Indonesia’s National Research and Innovation Agency (Badan Riset dan Inovasi Nasional BRIN) where we delved into the transformation of innovative research technology into clinical products for cell therapy. The discussion was incredibly insightful, highlighting the promising synergies between our expertise and BRIN’s vision for advancing healthcare through innovation. Looking […]

Mesenplify takes the stage in NTU!

We extend our sincere appreciation to Jolene from Nanyang Technological University Singapore Prof Yen Choo’s team for participating in our trial focusing on Mesenplify’s potential in osteogenic differentiation!

Engaging reseachers at Sun Yat-Sen University on Expanded Pluripotency!

🌟 Our Chief Scientific Officer, Jonathan, has been invited to share his expertise at Sun Yat-Sen University on Cell Fate Engineering in Expanded Pluripotent State and Early Development! 🧬 This is an incredible opportunity  to highlight the latest findings and progressions within the realm of developmental biology. And of course, to exchange knowledge and foster […]